尊龙Z6官方网站

中文
EN

HOME
ABOUT US
- Leadership
- Investors
- SAB
INVESTOR RELATIONS
- Announcements & Notices
- Financial Reports
- Listing Documents
- Investor Calendar
- Investor Presentation
- Corporate Governance
- Stock Information
- IR Contact
SCIENCE
NEWS & PRESS
- pressReleases
- newsMedia
CAREERS
- Career Openings
CONTACT US

Home

About Us

Leadership Investors SAB

Investor Relations

Announcements & Notices Financial Reports Listing Documents Investor Calendar Investor Presentation Corporate Governance Stock Information IR Contact

Science

Research Areas Pipeline Partnership

News&Press

Press Releases Media

Careers

Career Openings

中文
EN

About us

Founders

Our company was founded by a group of experienced drug hunters with strong passion, proven track records in drug discovery, and rich experience in managing multiple large R&D organizations.

Dr. Yao-Chang Xu

Founder & CEO

Dr. Hongping Yu

Co-founder, CSO

Drug discovery and development

Our R&D capabilities

We have established a fully integrated discovery platform that has successfully generated many novels and differentiated drug candidates. We continue to expeditiously advancing our programs in clinic and aim to accelerate time-to-market and successful commercialization. We are also making a broad range of efforts to maximize the therapeutic values of every program by expanding their indications and geographical coverage.